Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hirschmann-Jax

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Hematology/Oncology Clinics of North America|October 26, 2001
Cancer vaccinesR F Rousseau, C Hirschmann-Jax, S Takahashi, et al.
Cell Cycle (Georgetown, Tex.)|January 19, 2005
A distinct "side population" of cells in human tumor cells: implications for tumor biology and therapyC Hirschmann-Jax, A E Foster, G G Wulf, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2004
A distinct "side population" of cells with high drug efflux capacity in human tumor cellsC Hirschmann-Jax, A E Foster, G G Wulf, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Hematology/Oncology Clinics of North America|October 26, 2001
Cancer vaccinesR F Rousseau, C Hirschmann-Jax, S Takahashi, et al.
Cell Cycle (Georgetown, Tex.)|January 19, 2005
A distinct "side population" of cells in human tumor cells: implications for tumor biology and therapyC Hirschmann-Jax, A E Foster, G G Wulf, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2004
A distinct "side population" of cells with high drug efflux capacity in human tumor cellsC Hirschmann-Jax, A E Foster, G G Wulf, et al.
Pageof 1